You Bet Part of Your Paycheck on Axon. Now Manage the Bet.
Axon's eXponential Stock Plan is one of the boldest employee equity programs in America: moonshot units, a 3x earnings conversion, nine-year goals. It made real wealth on the way to the 2025 peak, and it has tested everyone's nerve in the drawdown since. I help Axon employees, a few minutes from your Scottsdale HQ, turn concentrated equity into a plan that survives both directions.
Schedule a conversation with JayXSUs Are Not Normal RSUs. Plan Accordingly.
The facts below come from Axon's SEC filings, because the XSP is unusual enough that secondhand descriptions get it wrong. Under the 2024 employee plan, every eligible US employee automatically received 60 XSUs, and employees could elect to convert future on-target earnings into additional XSUs at a 3x multiplier. The units vest across a nine-year program in 12 tranches, each tied to market-capitalization and operational goals, the same all-or-nothing architecture as the famous 2018 CEO award. The original 2019 plan worked the same way, and Axon employees collectively committed $75 million of their own compensation into it.
| XSP feature | What it means for your planning |
|---|---|
| Goal-based tranches | Vesting is lumpy and unpredictable: nothing for stretches, then a tranche lands as a large slug of ordinary income in whatever tax year the goals certify. Tax reserves and estimated payments matter more here than with calendar-vesting RSUs. |
| The 3x conversion election | Trading certain cash for leveraged equity is a real bet: your salary, your career, and your net worth all ride the same ticker. The right election size starts from your fixed expenses and existing concentration, not from optimism. |
| Nine-year horizon | Life happens inside nine years: home purchases, exits, market cycles. Your cash-flow plan has to work in the years where tranches do not vest. |
From $886 to Half That: The Drawdown Is a Planning Opportunity
Axon touched roughly $886 in August 2025 and has fallen about half from that peak since. If you have been vesting through both legs, you hold share lots with wildly different cost bases, some deep green, some red. That mix is exactly what tax-aware diversification is built for: selling high-basis lots sheds concentration at little or no gain, harvested losses can offset gains elsewhere, and each new vest is a fresh decision rather than a default hold. The expensive move is paralysis: waiting for the old high to come back before diversifying is a bet, not a plan.
Two tools to put numbers on it: model your tax at vest and the withholding gap, and read my guide to how much concentration is too much for the frameworks I use with clients.
On the rest of the benefits stack: Axon offers a 401(k) with employee-reported match figures that look competitive, but the formula is not publicly documented, so confirm it in your plan materials, and bring them to our conversation; sizing your 401(k) against your equity exposure is part of the same picture. Axon's Scottsdale headcount is also set to grow substantially under the HQ expansion the city approved in late 2025, which means a lot of new XSP participants making these decisions for the first time.
Plan terms referenced on this page are current as of July 2026; confirm the specifics with your benefits administrator. Jay Chang is not affiliated with, endorsed by, or sponsored by Axon Enterprise, Inc. or any of its subsidiaries. All company names and trademarks are the property of their respective owners.
Moonshot equity deserves grown-up planning.
Bring your grant statements and your last vest confirmation. I'll map your lots, your tax exposure, your concentration, and what the 3x election really costs and pays at your numbers.